PROCEPT BioRobotics Targets Positive Adjusted EBITDA in Q4 2026

Image: TokenPost
The company projects 2026 revenue of $390 million to $410 million and a full-year adjusted EBITDA loss of $30 million to $35 million.
Read the full story on TokenPostBeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.







